research Updated Integrated Safety Analysis of Ritlecitinib up to ~5 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials
Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.
Search
for
Sort by
Research
900-930 / 1000+ results
research Wnt/β-Catenin Signaling Pathway Targeting Androgenetic Alopecia: How Far Can We Go Beyond Minoxidil and Finasteride?
Targeting the Wnt/β-catenin pathway may lead to better treatments for hair loss.
research Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
Ritlecitinib is generally safe for alopecia areata patients over 72 months.
research Clinical diagnosis of COVID-19: a prompt, feasible, and sensitive diagnostic tool for COVID-19 based on a 1,757-patient cohort (The AndroCoV Clinical Scoring for COVID-19 diagnosis).
The AndroCoV Clinical Scoring is a quick, affordable, and accurate method for diagnosing COVID-19.
research Unveiling the Therapeutic Wealth of Eclipta Prostrata: Ethnobotany, Bioactive Compounds, and Biomedical Relevance
Eclipta prostrata is a medicinal herb with potential health benefits for various conditions and could be used in modern medicine.
research Immunologic and Autoimmune-Related Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection
research Prevalence and Pattern of Skin Manifestations in COVID-19 Patients; A Cross-Sectional Observational Study in Saudi Arabia
Some COVID-19 patients in Saudi Arabia had skin symptoms, with rashes being the most common.
research Characteristics of Women with HIV in the North of England
Many women with HIV in the North of England are diagnosed late and have other health conditions.
research SYSTEMIC IMPACT OF POST-CORONAVIRUS DISEASE SYNDROME IN BRAZIL
research Time of onset and duration of post-COVID-19 acute telogen effluvium
Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.
research Black dots in trichoscopy after COVID‐19. Can it be telogen effluvium?
A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.
research CORRELAÇÃO ENTRE COVID-19 E EFLÚVIO TELÓGENO E SEUS IMPACTOS SOCIAIS
COVID-19 may be linked to hair loss called Telogen Effluvium, affecting quality of life and self-esteem.
research Telogen effluvium associated with COVID‐19 infection
COVID-19 may cause hair loss due to infection stress or treatments.
research 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.
research Androgen receptor genetic variant predicts COVID‐19 disease severity: a prospective longitudinal study of hospitalized COVID‐19 male patients
A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.
research Expression of concern: potential risk for developing severe COVID-19 disease among anabolic steroid users
Anabolic steroid users may face higher risk of severe COVID-19.
research Comparison of survival of FU grafts trimmed chubby, medium, and skeletonized
The survival rates of hair grafts are similar regardless of how they are trimmed.
research Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.
research Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
A woman had hair loss, nail changes, and skin peeling after a COVID-19 infection, which got better on their own.
research Correlation Between Interest in COVID-19 Hair Loss and COVID-19 Surges: Analysis of Google Trends
Public interest in COVID-19-related hair loss increased during COVID-19 surges, especially with the omicron variant.
research Investigating self-reported hair loss following covid-19 infection in the Iraqi population
COVID-19 may cause hair loss, especially in young adults.
research Prevalence and Characterization of Long Covid-19 Symptoms in Health Care Professionals- A Need of the Hour
Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.
research Correlation Between Interest in COVID-19 Hair Loss and COVID-19 Surges: Analysis of Google Trends (Preprint)
Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.
research In response to the letter to the editor by Soha Ghanian et al. re our publication “Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males”
The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.
research Reply to comment on: The Gabrin sign
Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.
research Third World Congress of the International Academy of Cosmetic Dermatology
The Third World Congress of the International Academy of Cosmetic Dermatology discussed various topics like hair disorders, skin conditions, wound healing, shampoo technology, acne treatment, and the use of lasers in dermatology.
research Trend and Co-occurrence Network of COVID-19 Symptoms From Large-Scale Social Media Data: Infoveillance Study
Social media data can help track COVID-19 symptoms and predict the pandemic's status.
research Coronavirus is not the only corona we know in dermatology
The document lists various skin conditions and structures named "corona" that are not related to the coronavirus.
research A Mechanical-assisted Post-bioprinting Strategy for Challenging Bone Defects Repair
The new method improves bone repair by enhancing cell loading and stability in bioprinted scaffolds.
research The Potential of Cannabidiol for Acute Respiratory Distress Syndrome inCOVID-19
CBD may help manage severe lung issues in COVID-19 patients.